Butterfield CE

No ORCID on file · 2 papers in corpus · active 2002-2010
2010
Experimental and therapeutic medicine ·doi:10.3892/etm.2010.127

The chemotherapeutic agent etoposide is a topoisomerase II inhibitor widely used for cancer therapy. Low-dose oral etoposide, administered at close regular intervals, has potent anti-tumor activity in patients who are refractory to intraven…

2002
The Journal of clinical investigation ·doi:10.1172/jci15634

Several drugs approved for a variety of indications have been shown to exhibit antiangiogenic effects. Our study focuses on the PPARgamma ligand rosiglitazone, a compound widely used in the treatment of type 2 diabetes. We demonstrate, for …